BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee MS, Tesh VL. Roles of Shiga Toxins in Immunopathology. Toxins (Basel) 2019;11:E212. [PMID: 30970547 DOI: 10.3390/toxins11040212] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Kim J, Park JY, Park YJ, Park SY, Lee MS, Koo C. A portable and high-sensitivity optical sensing system for detecting fluorescently labeled enterohaemorrhagic Escherichia coli Shiga toxin 2B-subunit. PLoS One 2020;15:e0236043. [PMID: 32673369 DOI: 10.1371/journal.pone.0236043] [Reference Citation Analysis]
2 Detzner J, Klein AL, Pohlentz G, Krojnewski E, Humpf HU, Mellmann A, Karch H, Müthing J. Primary Human Renal Proximal Tubular Epithelial Cells (pHRPTEpiCs): Shiga Toxin (Stx) Glycosphingolipid Receptors, Stx Susceptibility, and Interaction with Membrane Microdomains. Toxins (Basel) 2021;13:529. [PMID: 34437399 DOI: 10.3390/toxins13080529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lee KS, Lee J, Lee P, Kim CU, Kim DJ, Jeong YJ, Park YJ, Tesh VL, Lee MS. Exosomes released from Shiga toxin 2a-treated human macrophages modulate inflammatory responses and induce cell death in toxin receptor expressing human cells. Cell Microbiol 2020;22:e13249. [PMID: 32772454 DOI: 10.1111/cmi.13249] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Yokoyama N, Hanafusa K, Hotta T, Oshima E, Iwabuchi K, Nakayama H. Multiplicity of Glycosphingolipid-Enriched Microdomain-Driven Immune Signaling. Int J Mol Sci 2021;22:9565. [PMID: 34502474 DOI: 10.3390/ijms22179565] [Reference Citation Analysis]
5 Slyke GV, Ehrbar DJ, Doering J, Yates JL, Vitetta ES, Donini O, Mantis NJ. Endpoint and epitope-specific antibody responses as correlates of vaccine-mediated protection of mice against ricin toxin. Vaccine 2020;38:6721-9. [PMID: 32891474 DOI: 10.1016/j.vaccine.2020.08.047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Varón Vega FA, Uribe Hernández AM, Buitrago-toro K. A propósito de complicaciones infrecuentes de enfermedades comunes. Síndrome de Ekiri. Infect 2020;25:67. [DOI: 10.22354/in.v25i1.913] [Reference Citation Analysis]
7 Kim JS, Lee MS, Kim JH. Recent Updates on Outbreaks of Shiga Toxin-Producing Escherichia coli and Its Potential Reservoirs. Front Cell Infect Microbiol 2020;10:273. [PMID: 32582571 DOI: 10.3389/fcimb.2020.00273] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
8 Lee KS, Jeong YJ, Lee MS. Escherichia coli Shiga Toxins and Gut Microbiota Interactions. Toxins (Basel) 2021;13:416. [PMID: 34208170 DOI: 10.3390/toxins13060416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Pan Z, Chen Y, McAllister TA, Gänzle M, Plastow G, Guan LL. Abundance and Expression of Shiga Toxin Genes in Escherichia coli at the Recto-Anal Junction Relates to Host Immune Genes. Front Cell Infect Microbiol 2021;11:633573. [PMID: 33816337 DOI: 10.3389/fcimb.2021.633573] [Reference Citation Analysis]
10 Mikolajczyk K, Bereznicka A, Szymczak-Kulus K, Haczkiewicz-Lesniak K, Szulc B, Olczak M, Rossowska J, Majorczyk E, Kapczynska K, Bovin N, Lisowska M, Kaczmarek R, Miazek A, Czerwinski M. Missing the sweet spot: one of the two N-glycans on human Gb3/CD77 synthase is expendable. Glycobiology 2021:cwab041. [PMID: 33978735 DOI: 10.1093/glycob/cwab041] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Amin MA, Hashem HR, El-mahallawy HS, Abdelrahman AA, Zaki HM, Azab MM. Characterization of enterohemorrhagic Escherichia coli from diarrhoeic patients with particular reference to production of Shiga-like toxin. Microbial Pathogenesis 2022;166:105538. [DOI: 10.1016/j.micpath.2022.105538] [Reference Citation Analysis]
12 Lee KS, Lee J, Lee P, Jeon BC, Song MY, Kwak S, Lee J, Kim JS, Kim DJ, Kim JH, Tesh VL, Lee MS, Park SK. Inhibition of O-GlcNAcylation protects from Shiga toxin-mediated cell injury and lethality in host. EMBO Mol Med 2021;:e14678. [PMID: 34842355 DOI: 10.15252/emmm.202114678] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Torti JF, Cuervo P, Nardello A, Pizarro M. Epidemiology and Characterization of Shiga Toxin-Producing Escherichia Coli of Hemolytic Uremic Syndrome in Argentina. Cureus 2021;13:e17213. [PMID: 34540440 DOI: 10.7759/cureus.17213] [Reference Citation Analysis]
14 Lee Y, Kim MH, Alves DR, Kim S, Lee LP, Sung JH, Park S. Gut-Kidney Axis on Chip for Studying Effects of Antibiotics on Risk of Hemolytic Uremic Syndrome by Shiga Toxin-Producing Escherichia coli. Toxins (Basel) 2021;13:775. [PMID: 34822559 DOI: 10.3390/toxins13110775] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Liu Y, Tian S, Thaker H, Dong M. Shiga Toxins: An Update on Host Factors and Biomedical Applications. Toxins (Basel) 2021;13:222. [PMID: 33803852 DOI: 10.3390/toxins13030222] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Landoni VI, Pittaluga JR, Carestia A, Castillo LA, Nebel MDC, Martire-greco D, Birnberg-weiss F, Schattner M, Schierloh P, Fernández GC. Neutrophil Extracellular Traps Induced by Shiga Toxin and Lipopolysaccharide-Treated Platelets Exacerbate Endothelial Cell Damage. Front Cell Infect Microbiol 2022;12:897019. [DOI: 10.3389/fcimb.2022.897019] [Reference Citation Analysis]
17 Montero DA, Del Canto F, Salazar JC, Céspedes S, Cádiz L, Arenas-Salinas M, Reyes J, Oñate Á, Vidal RM. Immunization of mice with chimeric antigens displaying selected epitopes confers protection against intestinal colonization and renal damage caused by Shiga toxin-producing Escherichia coli. NPJ Vaccines 2020;5:20. [PMID: 32194997 DOI: 10.1038/s41541-020-0168-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
18 Biernbaum EN, Kudva IT. AB5 Enterotoxin-Mediated Pathogenesis: Perspectives Gleaned from Shiga Toxins. Toxins (Basel) 2022;14:62. [PMID: 35051039 DOI: 10.3390/toxins14010062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Menge C. Molecular Biology of Escherichia Coli Shiga Toxins' Effects on Mammalian Cells. Toxins (Basel) 2020;12:E345. [PMID: 32456125 DOI: 10.3390/toxins12050345] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
20 Vinh PT, Shinohara Y, Yamada A, Duc HM, Nakayama M, Ozawa T, Sato J, Masuda Y, Honjoh KI, Miyamoto T. Baicalein Inhibits Stx1 and 2 of EHE: Effects of Baicalein on the Cytotoxicity, Production, and Secretion of Shiga Toxins of Enterohaemorrhagic Escherichia coli. Toxins (Basel) 2019;11:E505. [PMID: 31470657 DOI: 10.3390/toxins11090505] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
21 Varrone E, Carnicelli D, Brigotti M. Extracellular Vesicles and Renal Endothelial Cells: A Fatal Attraction in Hemolytic Uremic Syndrome. Am J Pathol 2021;191:795-804. [PMID: 33652019 DOI: 10.1016/j.ajpath.2021.02.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Szymczak-Kulus K, Weidler S, Bereznicka A, Mikolajczyk K, Kaczmarek R, Bednarz B, Zhang T, Urbaniak A, Olczak M, Park EY, Majorczyk E, Kapczynska K, Lukasiewicz J, Wuhrer M, Unverzagt C, Czerwinski M. Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry. J Biol Chem 2021;296:100299. [PMID: 33460651 DOI: 10.1016/j.jbc.2021.100299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
23 Johansson KE, Ståhl AL, Arvidsson I, Loos S, Tontanahal A, Rebetz J, Chromek M, Kristoffersson AC, Johannes L, Karpman D. Shiga toxin signals via ATP and its effect is blocked by purinergic receptor antagonism. Sci Rep 2019;9:14362. [PMID: 31591425 DOI: 10.1038/s41598-019-50692-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Detzner J, Pohlentz G, Müthing J. Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome. Toxins (Basel) 2020;12:E373. [PMID: 32512916 DOI: 10.3390/toxins12060373] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Kijewski A, Witsø IL, Iversen H, Rønning HT, L'Abée-Lund T, Wasteson Y, Lindbäck T, Aspholm M. Vitamin K Analogs Influence the Growth and Virulence Potential of Enterohemorrhagic Escherichia coli. Appl Environ Microbiol 2020;86:e00583-20. [PMID: 32769190 DOI: 10.1128/AEM.00583-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Pinto G, Almeida C, Azeredo J. Bacteriophages to control Shiga toxin-producing E. coli - safety and regulatory challenges. Crit Rev Biotechnol 2020;40:1081-97. [PMID: 32811194 DOI: 10.1080/07388551.2020.1805719] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
27 Tomino Y, Andoh M, Horiuchi Y, Shin J, Ai R, Nakamura T, Toda M, Yonemitsu K, Takano A, Shimoda H, Maeda K, Kodera Y, Oshima I, Takayama K, Inadome T, Shioya K, Fukazawa M, Ishihara K, Chuma T. Surveillance of Shiga toxin-producing Escherichia coli and Campylobacter spp. in wild Japanese deer (Cervus nippon) and boar (Sus scrofa). J Vet Med Sci 2020;82:1287-94. [PMID: 32655094 DOI: 10.1292/jvms.19-0265] [Reference Citation Analysis]
28 Golomidova AK, Efimov AD, Kulikov EE, Kuznetsov AS, Belalov IS, Letarov AV. O antigen restricts lysogenization of non-O157 Escherichia coli strains by Stx-converting bacteriophage phi24B. Sci Rep 2021;11:3035. [PMID: 33542282 DOI: 10.1038/s41598-021-82422-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Chen TJ, Feng Y, Liu T, Wu TT, Chen YJ, Li X, Li Q, Wu YC. Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson's Disease. Front Neurosci 2020;14:549037. [PMID: 33381005 DOI: 10.3389/fnins.2020.549037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
30 Cuesta CM, Guerri C, Ureña J, Pascual M. Role of Microbiota-Derived Extracellular Vesicles in Gut-Brain Communication. Int J Mol Sci 2021;22:4235. [PMID: 33921831 DOI: 10.3390/ijms22084235] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
31 Sun Z, Gu P, Xu H, Zhao W, Zhou Y, Zhou L, Zhang Z, Wang W, Han R, Chai X, An S. Human Umbilical Cord Mesenchymal Stem Cells Improve Locomotor Function in Parkinson’s Disease Mouse Model Through Regulating Intestinal Microorganisms. Front Cell Dev Biol 2022;9:808905. [DOI: 10.3389/fcell.2021.808905] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Nie JJ, Pian YY, Hu JH, Fan GQ, Zeng LT, Ouyang QG, Gao ZX, Liu Z, Wang CC, Liu Q, Cai JP. Increased systemic RNA oxidative damage and diagnostic value of RNA oxidative metabolites during Shigella flexneri-induced intestinal infection. World J Gastroenterol 2021; 27(37): 6248-6261 [PMID: 34712030 DOI: 10.3748/wjg.v27.i37.6248] [Reference Citation Analysis]